Cohesys
PrivateLast Round
Grant
Oct 13, 2025
Total Funding Raised
$3.51M
Company Overview
Cohesys operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in October 2025.
Cohesys is a medical device company that develops BoneTape, a bioresorbable fixation system for fracture repair intended to provide a less invasive alternative to metal plates and screws.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cohesys Comparables
Compare Cohesys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RevBio, Inc. | 85% | |
| KLS Martin Group | 80% | |
| Hangzhou Yuannang Biotechnology Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Cohesys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 13, 2025 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Jul 8, 2024 | ||||
| Grant | Jan 29, 2024 | ||||
| Grant | May 30, 2022 | ||||
Angel | Oct 14, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cohesys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Royal Bank Of Canada | Grant |
| Ontario Bioscience Innovation Organization | Grant |
| MedTech Innovator | Grant, Accelerator |
| U.S. Army Medical Research and Development Command | Grant |
| University of Toronto Asset Management Corporation | Grant |
| University of Toronto Early Stage Technology | Pre Seed, Grant |
| Creative Destruction Lab | Pre Seed, Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2025
Received $10K from Medical Technology Enterprise Consortium and Ontario Brain Institute.
- Jun 5, 2025
Received funding from MedTech Innovator.
For institutional investors. Book with your work email.
Cohesys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cohesys's valuation, stock price, and market status.
Is Cohesys a public or private company?
Cohesys is a private company.
What is the current stock price of Cohesys?
Cohesys is a private company, so its shares have no public market price. Caplight tracks Cohesys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cohesys worth (valuation)?
Valuation information for Cohesys is not publicly available.
Can I buy Cohesys stock?
Cohesys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cohesys's last funding round?
Cohesys's most recent funding round was Grant on October 13, 2025.
Who are the main investors in Cohesys?
Key investors in Cohesys include Royal Bank Of Canada, Ontario Bioscience Innovation Organization, MedTech Innovator, U.S. Army Medical Research and Development Command, University of Toronto Asset Management Corporation.
Will Cohesys IPO soon?
No public IPO plans have been announced for Cohesys.
How can I track Cohesys secondary market activity?
Caplight tracks bids, offers, and trades in Cohesys's shares on secondary markets.